Position
Creative Planning in Edgewise Therapeutics, Inc.
Back to the book · All holders of EWTX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $163.6K$24.82 → $31.50
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 24.5K | $607.2K | — | — | — | 0.0% |
| Q1 2026 | 31.3K | $984.9K | $31.50 | $163.6K | $214.2K | 0.0% |